Evolution of hypertensive disease: a revolution in guidelines.
Williams
Bryan
B
University of Leicester School of Medicine, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK. bw17@leicester.ac.uk
D000367:Age Factors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control
D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D049993:Sodium Chloride Symporter Inhibitors